Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer

The safety and immunological responsiveness of a peptide vaccine of ring finger protein 43 and 34-kDa translocase of the outer mitochondrial membrane combined with uracil-tegafur/leucovorin (UFT/LV) was previously demonstrated in metastatic colorectal cancer (CRC) in a phase I clinical trial. To cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Junichiro, Sugiura, Fumiaki, Sukegawa, Yasushi, Yoshioka, Yasumasa, Hida, Jin-Ichi, Hazama, Shoichi, Okuno, Kiyotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835896/
https://www.ncbi.nlm.nih.gov/pubmed/29541190
http://dx.doi.org/10.3892/ol.2018.7905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835896/
https://www.ncbi.nlm.nih.gov/pubmed/29541190
http://dx.doi.org/10.3892/ol.2018.7905

Ejemplares similares